Pharma sounds alarm over Grexit threats
This article was originally published in Scrip
As Greece prepares for a referendum that could bring it to the brink of an exit from the Eurozone, the European Federation of Pharmaceutical Industries and Associations ( EFPIA) has warned of the threats posed both to patients and to the pharma industry. Its director general Richard Bergström has written to the European Commissioner for Health Vytenis Andriukaitis and a number of business- and economy-focused commissioners calling urgently for a dialog to find solutions.
You may also be interested in...
Fundraising in the life sciences sector has been booming even as firms in many other industries are struggling to stay in business. Goodwin’s David Mardle is upbeat about the sector’s ongoing prospects – although M&A deals are currently proving tricky to complete.
See how much the CEOs and R&D heads of the world’s biggest pharma companies get paid, and how those companies are performing.
Merck & Co is gradually catching up with Roche in PD-1/L1 first-line triple-negative breast cancer treatment, but its presentation at ASCO on Keynote-355 includes mixed PFS results. Overall survival data will be key to Keytruda’s competitiveness.